These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 29651984)

  • 1. IFN-λ prevents influenza virus spread from the upper airways to the lungs and limits virus transmission.
    Klinkhammer J; Schnepf D; Ye L; Schwaderlapp M; Gad HH; Hartmann R; Garcin D; Mahlakõiv T; Staeheli P
    Elife; 2018 Apr; 7():. PubMed ID: 29651984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-λ drives distinct lung immune landscape changes and antiviral responses in human metapneumovirus infection.
    Sojati J; Parks OB; Zhang Y; Walters S; Lan J; Eddens T; Lou D; Fan L; Chen K; Oury TD; Williams JV
    mBio; 2024 May; 15(5):e0055024. PubMed ID: 38530032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dissemination of influenza B virus to the lower respiratory tract of mice is restricted by the interferon response.
    Schwab LSU; Do THT; Pilapitiya D; Koutsakos M
    J Virol; 2024 Jun; 98(6):e0160423. PubMed ID: 38780249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR2-mediated activation of innate responses in the upper airways confers antiviral protection of the lungs.
    Deliyannis G; Wong CY; McQuilten HA; Bachem A; Clarke M; Jia X; Horrocks K; Zeng W; Girkin J; Scott NE; Londrigan SL; Reading PC; Bartlett NW; Kedzierska K; Brown LE; Mercuri F; Demaison C; Jackson DC; Chua BY
    JCI Insight; 2021 Mar; 6(5):. PubMed ID: 33561017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-lambda contributes to innate immunity of mice against influenza A virus but not against hepatotropic viruses.
    Mordstein M; Kochs G; Dumoutier L; Renauld JC; Paludan SR; Klucher K; Staeheli P
    PLoS Pathog; 2008 Sep; 4(9):e1000151. PubMed ID: 18787692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-λ Mediates Non-redundant Front-Line Antiviral Protection against Influenza Virus Infection without Compromising Host Fitness.
    Galani IE; Triantafyllia V; Eleminiadou EE; Koltsida O; Stavropoulos A; Manioudaki M; Thanos D; Doyle SE; Kotenko SV; Thanopoulou K; Andreakos E
    Immunity; 2017 May; 46(5):875-890.e6. PubMed ID: 28514692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lambda interferon renders epithelial cells of the respiratory and gastrointestinal tracts resistant to viral infections.
    Mordstein M; Neugebauer E; Ditt V; Jessen B; Rieger T; Falcone V; Sorgeloos F; Ehl S; Mayer D; Kochs G; Schwemmle M; Günther S; Drosten C; Michiels T; Staeheli P
    J Virol; 2010 Jun; 84(11):5670-7. PubMed ID: 20335250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disruption of Type III Interferon (IFN) Genes
    Peterson ST; Kennedy EA; Brigleb PH; Taylor GM; Urbanek K; Bricker TL; Lee S; Shin H; Dermody TS; Boon ACM; Baldridge MT
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells.
    Benton KA; Misplon JA; Lo CY; Brutkiewicz RR; Prasad SA; Epstein SL
    J Immunol; 2001 Jun; 166(12):7437-45. PubMed ID: 11390496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bleomycin-Induced Lung Injury Increases Resistance to Influenza Virus Infection in a Type I Interferon-Dependent Manner.
    Seo SU; Jeong JH; Baek BS; Choi JM; Choi YS; Ko HJ; Kweon MN
    Front Immunol; 2021; 12():697162. PubMed ID: 34484196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of
    Baldridge MT; Lee S; Brown JJ; McAllister N; Urbanek K; Dermody TS; Nice TJ; Virgin HW
    J Virol; 2017 Apr; 91(7):. PubMed ID: 28077655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-λ enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin.
    Ye L; Schnepf D; Becker J; Ebert K; Tanriver Y; Bernasconi V; Gad HH; Hartmann R; Lycke N; Staeheli P
    Nat Immunol; 2019 May; 20(5):593-601. PubMed ID: 30886417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.
    Nguyen HH; van Ginkel FW; Vu HL; Novak MJ; McGhee JR; Mestecky J
    J Virol; 2000 Jun; 74(12):5495-501. PubMed ID: 10823854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of interferon in influenza virus tissue tropism.
    García-Sastre A; Durbin RK; Zheng H; Palese P; Gertner R; Levy DE; Durbin JE
    J Virol; 1998 Nov; 72(11):8550-8. PubMed ID: 9765393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-influenza virus effects of crude phenylethanoid glycosides isolated from ligustrum purpurascens via inducing endogenous interferon-γ.
    Hu XP; Shao MM; Song X; Wu XL; Qi L; Zheng K; Fan L; Liao CH; Li CY; He J; Hu YJ; Wu HQ; Li SH; Zhang J; Zhang FX; He ZD
    J Ethnopharmacol; 2016 Feb; 179():128-36. PubMed ID: 26190352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lambda interferon is the predominant interferon induced by influenza A virus infection in vivo.
    Jewell NA; Cline T; Mertz SE; Smirnov SV; Flaño E; Schindler C; Grieves JL; Durbin RK; Kotenko SV; Durbin JE
    J Virol; 2010 Nov; 84(21):11515-22. PubMed ID: 20739515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiviral activity of oral ultralow doses of antibodies to gamma-interferon: experimental study of influenza infection in mice].
    Sergeev AN; P'iankov OV; Shishkina LN; Duben' LG; Petrishchenko VA; Zhukov VA; P'iankova OG; Sviatchenko LI; Sherstoboev EIu; Karimova TV; Martiushev-Poklad AV; Sergeeva SA; Epshteĭn OI; Glotov AG; Glotova TI
    Antibiot Khimioter; 2004; 49(11):7-11. PubMed ID: 15945542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo.
    Teng O; Chen ST; Hsu TL; Sia SF; Cole S; Valkenburg SA; Hsu TY; Zheng JT; Tu W; Bruzzone R; Peiris JSM; Hsieh SL; Yen HL
    J Virol; 2017 Jan; 91(1):. PubMed ID: 27795434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initial infectious dose dictates the innate, adaptive, and memory responses to influenza in the respiratory tract.
    Marois I; Cloutier A; Garneau É; Richter MV
    J Leukoc Biol; 2012 Jul; 92(1):107-21. PubMed ID: 22504848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Flavonoid Isoliquiritigenin Reduces Lung Inflammation and Mouse Morbidity during Influenza Virus Infection.
    Traboulsi H; Cloutier A; Boyapelly K; Bonin MA; Marsault É; Cantin AM; Richter MV
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6317-27. PubMed ID: 26248373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.